About Lisa Foster
Articles by Lisa Foster
What Are Hypomethylating Agents And How Do They Treat CMML?Mar 10, 2025
March Is Kidney Disease Awareness Month!Mar 04, 2025
Olutasidenib Study Results for Relapsed/Refractory AMLFeb 11, 2025
FDA Approves Ozempic to Reduce Kidney Disease Progression in Patients with Type 2 DiabetesFeb 04, 2025
Breaking New Ground: The Promise of Nemtabrutinib in Treating Relapsed Follicular LymphomaDec 31, 2024
Studying Quality of Life With and Without Elotuzumab in Newly Diagnosed MyelomaDec 18, 2024
What Are Cytokine Receptors and How Do They Affect Acute Lymphoblastic Leukemia (ALL)?Dec 05, 2024
What Do We Know About Pediatric Acute Lymphoblastic Leukemia (ALL)?Dec 04, 2024
Pediatric B-Cell Acute Lymphoblastic Leukemia (B-ALL): Breakthrough Insights and Optimized TreatmentsDec 03, 2024
Understanding Acute Lymphoblastic Leukemia (ALL) in Children: Symptoms, Causes, and Treatment OptionsDec 01, 2024
Factors That Can Influence How Well CAR T-Cell Therapy Works for MCLNov 25, 2024
What is Ruxolitinib for Polycythemia Vera (PV)?Nov 22, 2024
What are the Subtypes of T-Cell Lymphoma?Nov 22, 2024
A New PV Treatment in Clinical Trials: RusfertideNov 20, 2024
What is Besremi for Polycythemia Vera (PV)?Nov 04, 2024
What Does My ALL Symptoms, Remission and Relapse Look Like?Nov 01, 2024
A New CAR T-Cell Therapy Treatment for ALLNov 01, 2024
The First Medication To Treat CD19+ Acute Lymphoblastic LeukemiaNov 01, 2024
Is it Safe for R/R DLBCL Patients to Receive CAR T-cell Therapy in an Outpatient Setting?Oct 22, 2024
How One DLBCL Therapy Is Proving Its Worth: Three Years LaterOct 15, 2024
NPM1 Mutation in AML: Prognosis, Testing, & TreatmentsOct 04, 2024
Brainwave Monitoring May Reduce the Need for Invasive Tests in DLBCL Patients Receiving CAR T-Cell TherapySep 24, 2024
New Treatment For Follicular Lymphoma: Understanding BTK InhibitorsSep 13, 2024
Understanding Carfilzomib Dosing for Multiple MyelomaSep 03, 2024
